Skip to main content
Premium Trial:

Request an Annual Quote

Proteomics International Snatches $1M Grant to Develop Kidney Disease Biomarkers for CDx

NEW YORK (GenomeWeb News) – The Australian government has awarded Proteomics International A$1 million (US$ 1 million) to develop biomarkers for diabetic kidney disease into a companion diagnostic test.

The funding from Commercialisation Australia — a merit-based, competitive assistance program — will be used by Perth, Australia-based Proteomics International to further validate its discovered biomarkers by performing additional analysis on patient groups. The work, the company said, should result in a more sensitive and effective molecular diagnostic test that will be able to predict kidney disease and monitor its progression in patients.

"Importantly, a companion diagnostic test that is being developed with these biomarkers may help to produce new personalized medicines, and in a shorter time frame," Richard Lipscombe, managing director of Proteomics International, said in a statement. "This could deliver optimal therapy for certain groups of patients and identify those patients where medicine would be less effective or cause side effects."

Proteomics International is a mass spectrometry-based drug discovery and contract research organization.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.